The global long read sequencing market was valued at $724.4 million in 2022, and is projected to reach $5.2 billion by 2032, growing at a CAGR of 21.7% from 2023 to 2032.
Report Code : A14421 | Pages : 395 | Category : Life Sciences
Global hydrocephalus market was valued at $6907.5 million in 2020 and is projected to reach $10178.6 million by 2030, registering a CAGR of 4.0% from 2021 to 2030.
Report Code : A14991 | Pages : 280 | Category : Life Sciences
The global respiratory pathogen testing kits market was valued at $2.2 billion in 2021, and is projected to reach $3.7 billion by 2031, growing at a CAGR of 5.5% from 2022 to 2031.
Report Code : A15060 | Pages : 220 | Category : Life Sciences
The global cholesterol test market was valued at $8,537.52 million in 2021 and is projected to reach $18,441.91 million by 2031, growing at a CAGR of 8% from 2022 to 2031.
Report Code : A15370 | Pages : 204 | Category : Life Sciences
The global central lab market was valued at $3.3 billion in 2021, and is projected to reach $6 billion by 2031, growing at a CAGR of 6% from 2022 to 2031.
Report Code : A15406 | Pages : 223 | Category : Life Sciences
The global Multiplexed Diagnostics Market was valued at $10.7 billion in 2022, and is projected to reach $41.5 billion by 2032, growing at a CAGR of 14.5% from 2023 to 2032.
Report Code : A15440 | Pages : 425 | Category : Life Sciences
The global histology and cytology market was valued at $7.2 billion in 2022, and is projected to reach $22.2 billion by 2032, growing at a CAGR of 11.9% from 2023 to 2032.
Report Code : A15397 | Pages : 298 | Category : Life Sciences
The global hepatitis e diagnostic tests market was valued at $61.7 million in 2021, and is projected to reach $93.5 million by 2031, growing at a CAGR of 4.2% from 2022 to 2031.
Report Code : A15447 | Pages : 171 | Category : Life Sciences
The global syphilis immunoassay diagnostics market was valued at $315.5 million in 2021, and is projected to reach $446.0 million by 2031, growing at a CAGR of 3.5% from 2022 to 2031.
Report Code : A15454 | Pages : 247 | Category : Life Sciences
The global bacterial cell culture market was valued at $2.8 billion in 2021, and is projected to reach $5.2 billion by 2031, growing at a CAGR of 6.3% from 2022 to 2031.
Report Code : A15641 | Pages : 273 | Category : Life Sciences
The global microfluidic devices market was valued at $21.7 billion in 2021, and is projected to reach $158.1 billion by 2031, growing at a CAGR of 22.4% from 2021 to 2031.
Report Code : A17085 | Pages : 220 | Category : Life Sciences
The global tumor ablation market was valued at $1.6 billion in 2023, and is projected to reach $7.5 billion by 2035, growing at a CAGR of 13.6% from 2024 to 2035.
Report Code : A17208 | Pages : 372 | Category : Life Sciences
The global hepatitis c testing market was valued at $1.5 billion in 2023, and is projected to reach $2.6 billion by 2035, growing at a CAGR of 4.9% from 2024 to 2035.
Report Code : A17601 | Pages : 312 | Category : Life Sciences
Driven by various major factors, Canada Specialty Enzymes Market is anticipated to create potential opportunity for prominent vendors operating in U.S. country by the end of 2031.
Report Code : A18163 | Category : Life Sciences
U.S. country dominated the market in 2022 and is expected to maintain its dominance by the end of the forecast period.
Report Code : A18165 | Category : Life Sciences
In market Type, Carbohydrases holds the largest revenue share during the analysis period and Type is expected to exhibit the highest CAGR over the analysis period.
Report Code : A18167 | Category : Life Sciences
The Carbohydrases is the most lucrative in terms of revenue growth in North America Specialty Enzymes Market. The report analyses the market using Porter’s Five Forces Analysis, Top player Positioning and COVID-19 Impact Analysis.
Report Code : A18161 | Category : Life Sciences
The U.S. Specialty Enzymes Market study provides detailed analysis on major drivers, restraints, trends, opportunities, and key player strategies impacting overall performance of market throughout the forecast period.
Report Code : A18162 | Category : Life Sciences
In addition, the study also offers an all-encompassing analysis of the plans & policies implemented by the major players throughout the COVID-19 period. U.S. holds a dominant position in 2031 and would continue to maintain the lead over the forecast period.
Report Code : A18164 | Category : Life Sciences
The France Specialty Enzymes Market report covers the drivers, restraints, and opportunities of the market. It focuses on the current market strategies adopted by the key players in the industry. The France Specialty Enzymes Market report covers profile of leading stakeholders operating in the France.
Report Code : A18166 | Category : Life Sciences
The Germany Specialty Enzymes Market report covers the drivers, restraints, and opportunities of the market. It focuses on the current market strategies adopted by the key players in the industry. The Germany Specialty Enzymes Market report covers profile of leading stakeholders operating in the Germany.
Report Code : A18168 | Category : Life Sciences
The Spain Specialty Enzymes Market report covers the drivers, restraints, and opportunities of the market. It focuses on the current market strategies adopted by the key players in the industry. The Spain Specialty Enzymes Market report covers profile of leading stakeholders operating in the Spain.
Report Code : A18169 | Category : Life Sciences
In market Type, Carbohydrases holds the largest revenue share during the analysis period and Type is expected to exhibit the highest CAGR over the analysis period.
Report Code : A18170 | Category : Life Sciences
Driven by various major factors, Japan Specialty Enzymes Market is anticipated to create potential opportunity for prominent vendors operating in U.S. country by the end of 2031.
Report Code : A18173 | Category : Life Sciences
In market Type, Carbohydrases holds the largest revenue share during the analysis period and Type is expected to exhibit the highest CAGR over the analysis period.
Report Code : A18175 | Category : Life Sciences
